MANGROVE PARTNERS IM, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001535392

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHigh Turnover how tags are computed

Q1 2024 · 160 positions · Total reported value $1.42B · Top-10 concentration 29.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 69.6% · 143 new · 48 cut · 205 exited

Active Share (vs S&P 500): 99.2% · vs QQQ: 99.6% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -8.2% · vs SPY -10.3% · Prev Value $1.52B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +4.0% · vs SPY +1.8% · Latest Value $1.47B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2024 13F filing, MANGROVE PARTNERS IM, LLC disclosed 160 equity positions with a combined reported value of $1.42B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 29.6% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.

The largest disclosed positions as of Q1 2024 were MBC ($50.36M), AER ($47.80M), ACI ($45.84M). By sector, the heaviest allocations are Consumer Discretionary 18.0%, Financials 12.6%. Versus the prior quarter, allocation shifted toward Health Care (+5.6pp), Consumer Staples (+3.2pp) and away from Technology (-1.6pp), Real Estate (-1.9pp).

Versus the prior quarter, MANGROVE PARTNERS IM, LLC opened 143 new positions, trimmed 48 and fully exited 205, a turnover rate of 69.6% of positions. The portfolio's overlap with the prior quarter was 67% of names.

The largest new positions opened in Q1 2024 were TEVA ($38.97M), AGR ($36.51M), WS ($31.51M).

Of the 205 positions fully exited versus the prior quarter, the largest were MRTX ($64.73M), WFRD ($56.82M), DELL ($37.46M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2024)

  • TEVA TEVA PHARMACEUTICAL INDS LTD · $38.97M
  • AGR AVANGRID INC · $36.51M
  • WS WORTHINGTON STL INC · $31.51M
  • CTLT CATALENT INC · $26.08M
  • JNPR JUNIPER NETWORKS INC · $23.45M
  • ANAB ANAPTYSBIO INC · $15.53M
  • HA HAWAIIAN HOLDINGS INC · $14.86M
  • OLK OLINK HLDG AB · $12.70M

Fully Exited (vs previous quarter)

  • MRTX MIRATI THERAPEUTICS INC · prev qtr: $64.73M
  • WFRD WEATHERFORD INTL PLC · prev qtr: $56.82M
  • DELL DELL TECHNOLOGIES INC · prev qtr: $37.46M
  • SPLK SPLUNK INC · prev qtr: $32.00M
  • ESAB ESAB CORPORATION · prev qtr: $31.16M
  • SOVO SOVOS BRANDS INC · prev qtr: $15.86M
  • FBIN FORTUNE BRANDS INNOVATIONS I · prev qtr: $15.31M
  • CNNE CANNAE HLDGS INC · prev qtr: $12.40M

Insider Transactions (Form 4)

Latest MANGROVE PARTNERS IM, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Mangrove Partners IM is an SEC-registered 13F filer based in Greenwich, CT, United States. As of Q2 2026 it reported 426 US equity positions with a combined value of $1.52B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: GREENWICH, CT, United States
  • SEC registration: 801-78070 (status: Approved), registered 2013-05-20
  • Regulatory AUM (Form ADV): $2.71B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: mangrovepartners.com

Portfolio Structure

  • 426 positions · $1.52B reported value (Q2 2026)
  • Top 10 holdings = 38.1% of reported value
  • Largest position: INDV (INDIVIOR PHARMACEUTICALS INC) at 7.2%
  • Average position size: $3.57M

Sector Tilt

  • Consumer Discretionary 20.8%
  • Financials 18.5%
  • Information Technology 13.9%
  • (classified holdings cover 89% of value)

Quarterly Activity

  • Q2 2026: 198 new, 40 added, 61 reduced, 199 exited
  • 127 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Financials 12.6%
Technology 5.9%
Energy 2.2%
Other 43.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 2.69M $50.36M 3.54%
3.54%
Hold
2 550.01K $47.80M 3.36%
3.36%
Hold
3 2.14M $45.84M 3.23%
3.23%
Add
4 691.87K $45.76M 3.22%
3.22%
Hold
5 1.09M $44.42M 3.13%
3.13%
Add
6 1.26M $40.79M 2.87%
2.87%
Add
7 2.76M $38.97M 2.74%
2.74%
New
8 1.00M $36.51M 2.57%
2.57%
New
9 565.01K $35.50M 2.50%
2.50%
Hold
10 1.29M $34.48M 2.43%
2.43%
Hold
11 419.90K $31.60M 2.22%
2.22%
Hold
12 878.86K $31.51M 2.22%
2.22%
New
13 203.24K $30.67M 2.16%
2.16%
Hold
14 2.05M $29.85M 2.10%
2.10%
Hold
15 8.75M $28.88M 2.03%
2.03%
Hold
16 813.04K $27.20M 1.91%
1.91%
Hold
17 461.98K $26.08M 1.83%
1.83%
New
18 1.15M $25.96M 1.83%
1.83%
Hold
19 1.55M $25.73M 1.81%
1.81%
Add
20 586.53K $25.70M 1.81%
1.81%
Hold
21 223.30K $24.68M 1.74%
1.74%
Reduce
22 264.83K $24.41M 1.72%
1.72%
Add
23 632.68K $23.45M 1.65%
1.65%
New
24 326.75K $21.03M 1.48%
1.48%
Hold
25 659.55K $20.26M 1.43%
1.43%
Hold
26 405.34K $18.36M 1.29%
1.29%
Add
27 318.77K $18.11M 1.27%
1.27%
Reduce
28 338.64K $18.06M 1.27%
1.27%
Hold
29 7.12M $17.59M 1.24%
1.24%
Reduce
30 574.87K $16.65M 1.17%
1.17%
Hold
31 689.52K $15.53M 1.09%
1.09%
New
32 1.12M $14.86M 1.05%
1.05%
New
33 1.28M $14.20M 1.00%
1.00%
Hold
34 439.31K $12.71M 0.89%
0.89%
Hold
35 540.37K $12.70M 0.89%
0.89%
New
36 930.09K $11.81M 0.83%
0.83%
Hold
37 173.87K $10.82M 0.76%
0.76%
Hold
38 1.94M $10.82M 0.76%
0.76%
Add
39 951.09K $10.55M 0.74%
0.74%
Hold
40 950.00K $10.38M 0.73%
0.73%
Hold
41 950.10K $10.27M 0.72%
0.72%
Hold
42 949.91K $10.22M 0.72%
0.72%
Hold
43 900.00K $10.17M 0.72%
0.72%
Hold
44 906.10K $10.04M 0.71%
0.71%
Hold
45 900.00K $9.96M 0.70%
0.70%
Hold
46 660.63K $9.81M 0.69%
0.69%
Add
47 904.00K $9.79M 0.69%
0.69%
Hold
48 896.70K $9.60M 0.68%
0.68%
Hold
49 850.75K $9.25M 0.65%
0.65%
Hold
50 5.58M $8.93M 0.63%
0.63%
Hold

FAQ

What did MANGROVE PARTNERS IM, LLC buy in 2024-Q1?

In its 2024-Q1 13F filing, MANGROVE PARTNERS IM, LLC reported 160 equity positions worth $1.42B in aggregate; its largest disclosed positions were MBC ($50.36M), AER ($47.80M), ACI ($45.84M).

How large is MANGROVE PARTNERS IM, LLC's portfolio?

MANGROVE PARTNERS IM, LLC reported $1.42B of long equity holdings across 160 positions as of 2024-Q1. Top-10 holdings account for 29.6% of reported value.

What is MANGROVE PARTNERS IM, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/mangrove-partners-im/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →